|
Volumn 25, Issue 10, 2006, Pages 1628-1638
|
Commitee for medicinal products for human use (CHMP) guideline on the choice of the non-inferiority margin
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
PLACEBO;
BIOEQUIVALENCE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SAFETY;
DRUG UTILIZATION;
HUMAN;
MEDICAL RESEARCH;
PRACTICE GUIDELINE;
PROFESSIONAL STANDARD;
RISK BENEFIT ANALYSIS;
SENSITIVITY ANALYSIS;
STATISTICAL ANALYSIS;
STATISTICS;
ARTICLE;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
EUROPEAN UNION;
METHODOLOGY;
PHARMACOKINETICS;
STANDARD;
CLINICAL TRIALS;
CONFIDENCE INTERVALS;
DATA INTERPRETATION, STATISTICAL;
EUROPEAN UNION;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
THERAPEUTIC EQUIVALENCY;
|
EID: 33646759912
PISSN: 02776715
EISSN: 10970258
Source Type: Journal
DOI: 10.1002/sim.2584 Document Type: Conference Paper |
Times cited : (89)
|
References (0)
|